Accelerating Regenerative Medicine
Empowering Cell & Gene Therapy with AI
with AI
CytoHub is not just building a company—we are engineering the future of heart failure treatment.
The CytoHub Platform Quadrant
Recent News
Rahul Singhvi, ScD, Co-Founder of National Resilience, joins CytoHub as an Advisor to advance the development of life-saving therapies for patients.
LA JOLLA, Calif.–(BUSINESS WIRE)–CytoHub, Inc., a pioneering developer of intelligent technologies for cell therapy and regenerative medicine, today announced the strategic addition of three top industry experts to its team.
Mohammad El-Kalay, PhD joins CytoHub as an Advisor, brings 35+ years of manufacturing and technical leadership to advance the development of RegenMed.
LA JOLLA, Calif.–(BUSINESS WIRE)–CytoHub, Inc., a pioneering developer of intelligent technologies for cell therapy and regenerative medicine, today announced the strategic addition of three top industry experts to its team.
Richard J. Anderson, Ph.D., joins CytoHub as VP, Technical Operations, brings over 25+ years technical leadership of cellular therapy products.
LA JOLLA, Calif.–(BUSINESS WIRE)–CytoHub, Inc., a pioneering developer of intelligent technologies for cell therapy and regenerative medicine, today announced the strategic addition of three top industry experts to its team.
LA JOLLA, Calif.–(BUSINESS WIRE)–CytoHub, Inc., a pioneering developer of intelligent technologies for cell therapy and regenerative medicine, today announced the strategic addition of three top industry experts to its team.
CytoHub is transforming the future how cardiac drugs are discovered and developed, paving the way of regenerative medicine commercialization.
HeartReady™
CardioVive™
CytoScale™
BioEngineAI™
We partner & adopt the best-in-class models & technology
